Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists NEW YORK, NY, April 14, 2021—Research to Prevent Blindness is pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases. The Award is aimed at early- to mid-career
TGF News
New Grant Topic Announced
Forecasting Glaucoma Disease Progression with Artificial Intelligence MAJOR GAPS IN GLAUCOMA CARE: We currently have no way to forecast glaucoma disease progression or make predictions about whether patients will require incisional surgery or be blinded by glaucoma. Also, decisions about target IOP are arbitrary and based on clinical consideration of patient age, amount of baseline damage, and baseline IOP. The Glaucoma Foundation (TGF)
Ways to Look and Feel Your Best in 2021
[caption id="attachment_3261" align="aligncenter" width="300"] Photo Credit: Pexels[/caption] We’re coming out of a challenging year. Although vaccine distribution provides a light at the end of the tunnel, we still have a ways to go. Whether you’re stuck at home or safely navigating the world, it’s important to find ways to look and feel your best. These forms of self-care can give
New Fellowships Support Under-Represented Minorities in Glaucoma Research
The Glaucoma Foundation and Research to Prevent Blindness have partnered to provide five fellowships in 2021 to increase innovation and diversity in glaucoma research. NEW YORK, March 10, 2021 – The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit
Update on Home Tonometry: An Easy Way to Track Your IOP
TGF invites you to learn about "MyEYES" Please join us on Tuesday, March 9, 2021 - 5 pm EDT MyEYES is dedicated to helping you better manage your glaucoma with access to the personal tonometer, iCare HOME. Medical devices that are required for testing or diagnostics are often prohibitively expensive and sometimes hard to access. In order to provide patients
“Bringing the Latest Glaucoma Science Directly to the Patient” – A Live Online Seminar with Q&A
On Saturday, February 27, 2021 from 10 am to noon Eastern Daylight Time on ZOOM, The Glaucoma Foundation will present an online seminar with two Q&A sessions, “Bringing the Latest Glaucoma Science Directly to the Patient.” Four experts will discuss issues of importance to glaucoma patients, clinicians and researchers including advances in glaucoma diagnosis and treatment and the role of
Clinical Glaucoma Trials
Nearly all treatments, including drugs and medical devices, require clinical trials and approval by the government’s Food and Drug Administration (FDA). The journey from a scientific breakthrough to a treatment you can access is a long one -- taking years. (The recent approvals of COVID-19 vaccines are welcome exceptions to that timeframe.) A clinical trial is a research study using
Glaucoma Awareness Month – Be Well-Informed
January is Glaucoma Awareness Month Be Well-Informed Here’s a New Year’s resolution that can save your sight: make that call to schedule an appointment to have your eyes tested. The pandemic forced many offices to close in early spring but many reopened in the summer, although often seeing fewer patients than before the pandemic. While COVID 19 is still rampant
Glaucoma Awareness Month
January is Glaucoma Awareness Month Glaucoma is a leading cause of vision loss and blindness in the United States. Right now, there are as many as 40 million people around the world who aren’t yet aware that glaucoma is silently stealing their sight. Glaucoma can sneak up on you. And though there isn’t yet a cure, early detection and treatment
Genetics Research
Doctor, I Have A Question: What's New in Genetics Research? Our Scientific Advisory Board Member Dr. John H. Fingert, MD, PhD shares some of the new developments in glaucoma and genetics research. Click the image below to enlarge the article.